Dishevelled binding antagonist of beta catenin 1 (DACT1)

Dishevelled binding antagonist of beta catenin 1 (DACT1) is a cytoplasmic adaptor and scaffold protein that modulates canonical and non-canonical Wnt signaling pathways by direct interaction with Dishevelled (Dvl) proteins. DACT1 is characterized by intrinsically disordered domains, PDZ-binding motifs, and acts primarily to regulate intracellular signal transduction, morphogenesis, fat cell differentiation, and synaptic development. DACT1 controls β-catenin levels through regulation of Dishevelled activity and localization, thereby influencing cell proliferation, apoptosis, and migration. It functions as a tumor suppressor in several cancers, including breast cancer, where its loss is associated with epigenetic promoter methylation and poor prognosis. In development, mutations or altered expression lead to severe congenital defects. DACT1 also forms membrane-less biomolecular condensates (Frodosomes) that orchestrate multiprotein signaling complexes necessary for cell polarity and tissue morphogenesis[1][2][3][4].

Other names

Dapper homolog 1DACT1DPR1HNG3hDPR1DAPPER1THYEX3HDPR1DAPPERFRODODapper antagonist of catenin 1hepatocellular carcinoma novel gene 3 proteinTBS2

Epigenetic regulation (promoter methylation leading to DACT1 silencing in cancer); Modulation of Wnt/β-catenin signaling by binding and sequestering Dishevelled (Dvl), affecting β-catenin levels; Scaffold-mediated formation of biomolecular condensates